Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2026	Mar. 31, 2025
Net cash flows from operating activities:
Net income (loss)	$ 1,417	$ (505)
Adjustments to reconcile net income (loss) to net cash from operating activities:
Depreciation and amortization	6,340	5,446
Non-cash compensation	8,414	8,045
Non-cash lease expense	1,297	1,226
Write-down of inventories and deferred preservation costs	1,062	1,312
Deferred income taxes	(524)	0
Change in fair value of contingent consideration	1,740	(2,830)
Other	537	(2,891)
Changes in operating assets and liabilities:
Receivables	(2,760)	(7,922)
Inventories and deferred preservation costs	(6,379)	(2,453)
Prepaid expenses and other assets	(1,286)	(327)
Accounts payable, accrued expenses, and other liabilities	(8,704)	(16,054)
Net cash flows provided by (used in) operating activities	1,154	(16,953)
Net cash flows from investing activities:
Capital expenditures	(8,003)	(3,638)
Payments related to sale of non-financial assets	(1,500)	0
Payments for Endospan agreements	(1,000)	0
Net cash flows used in investing activities	(10,503)	(3,638)
Net cash flows from financing activities:
Repayment of debt	0	(66)
Proceeds from exercise of stock options and issuance of common stock	1,250	4,181
Principal payments on short-term notes payable	(577)	0
Other	(210)	(178)
Net cash flows provided by financing activities	463	3,937
Effect of exchange rate changes on cash and cash equivalents	(258)	884
Decrease in cash and cash equivalents	(9,144)	(15,770)
Cash and cash equivalents beginning of period	64,908	53,463
Cash and cash equivalents end of period	$ 55,764	$ 37,693